Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective concentration of ropivacaine for breakthrough pain during epidural labor analgesia
ChiCTR2200064127Phase 4Not yet recruiting
- Sponsor
- Dongguan Maternal and Child Health Care Hospital
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in labor pain (3 arms), sponsored by Dongguan Maternal and Child Health Care Hospital. Primary endpoints: numerical rating scale (NRS) score and Improved Bromage (MBS) score. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2200064127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064127.